Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,238 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $203.11 | 10 | $0 (2024) |
| Allergan, Inc. | $147.39 | 9 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $139.96 | 2 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $124.42 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $105.68 | 6 | $0 (2019) |
| TISSUETECH, INC. | $103.08 | 13 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $71.38 | 4 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $52.70 | 1 | $0 (2019) |
| Glaukos Corporation | $43.06 | 1 | $0 (2017) |
| Shire North American Group Inc | $42.50 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.40 | 4 | BIOTISSUE HOLDINGS INC. ($76.40) |
| 2023 | $103.05 | 5 | BIOTISSUE HOLDINGS, INC. ($86.42) |
| 2022 | $85.40 | 4 | BioTissue Holdings, Inc. ($40.29) |
| 2021 | $106.34 | 10 | TISSUETECH, INC. ($63.65) |
| 2020 | $101.71 | 10 | Allergan, Inc. ($45.54) |
| 2019 | $446.51 | 13 | Kala Pharmaceuticals, Inc. ($139.96) |
| 2018 | $152.58 | 8 | Shire North American Group Inc ($42.50) |
| 2017 | $165.77 | 7 | Glaukos Corporation ($43.06) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| 08/19/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| 08/19/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| 10/26/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Ophthalmology | ||||||
| 05/29/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 05/29/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 05/29/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 01/23/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 10/14/2022 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Ophthalmology | ||||||
| 07/14/2022 | Bausch & Lomb Americas Inc. | LOTEMAX SM (Drug), VYZULTA, LOTEMAX SM | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 06/29/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 06/29/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 12/10/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 11/18/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 11/17/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 11/12/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 10/21/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 08/20/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: GLAUCOMA | ||||||
| 06/15/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/19/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: GLAUCOMA | ||||||
| 02/08/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 01/22/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/23/2020 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: Medical Device (510K) | ||||||
| 10/27/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,441 | 3,134 | $342,998 | $171,213 |
| 2022 | 12 | 2,617 | 3,251 | $360,183 | $180,234 |
| 2021 | 14 | 3,320 | 4,051 | $565,788 | $256,245 |
| 2020 | 16 | 3,326 | 3,828 | $594,976 | $245,070 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 576 | 1,108 | $98,612 | $63,773 | 64.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 407 | 423 | $64,296 | $33,188 | 51.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 499 | 573 | $63,603 | $24,445 | 38.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 440 | 448 | $32,256 | $10,702 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 123 | $16,236 | $10,102 | 62.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 136 | 162 | $17,334 | $9,493 | 54.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 35 | 38 | $21,402 | $9,258 | 43.3% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 18 | 18 | $11,880 | $3,128 | 26.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 32 | 32 | $6,048 | $2,431 | 40.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 85 | 98 | $4,018 | $1,644 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,926 | $1,408 | 48.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 52 | $3,172 | $1,317 | 41.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 45 | 45 | $1,215 | $324.64 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 550 | 982 | $87,597 | $56,879 | 64.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 419 | 438 | $66,576 | $34,911 | 52.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 509 | 586 | $65,046 | $24,224 | 37.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 47 | 55 | $29,082 | $13,651 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 146 | $19,395 | $12,252 | 63.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 165 | 202 | $21,614 | $11,382 | 52.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 439 | 443 | $31,896 | $10,553 | 33.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 172 | 201 | $12,261 | $7,277 | 59.4% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2022 | 21 | 22 | $14,520 | $3,916 | 27.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 38 | 38 | $7,182 | $3,146 | 43.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 82 | 92 | $3,772 | $1,719 | 45.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 46 | 46 | $1,242 | $324.85 | 26.2% |
About Dr. Daniel Messner, MD
Dr. Daniel Messner, MD is a Glaucoma Specialist healthcare provider based in Southern Pines, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396736617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Messner, MD has received a total of $1,238 in payments from pharmaceutical and medical device companies, with $76.40 received in 2024. These payments were reported across 61 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,238).
As a Medicare-enrolled provider, Messner has provided services to 11,704 Medicare beneficiaries, totaling 14,264 services with total Medicare billing of $852,762. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Glaucoma Specialist
- Other Specialties Ophthalmology
- Location Southern Pines, NC
- Active Since 11/04/2005
- Last Updated 04/20/2022
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1396736617
Products in Payments
- PROKERA (Device) $190.36
- INVELTYS (Drug) $139.96
- Rhopressa (Drug) $107.68
- LUMIGAN (Drug) $75.21
- XIIDRA (Drug) $62.41
- DURYSTA (Drug) $57.49
- FORUM (Device) $52.70
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $43.06
- TRAVATAN Z (Drug) $41.40
- Prokera (Device) $39.43
- PROLENSA (Drug) $37.69
- LOTEMAX SM (Drug) $36.53
- Tecnis 1-piece IOL (Device) $35.39
- Zioptan (Drug) $31.39
- Cimerli (Biological) $26.58
- DUREZOL (Drug) $22.33
- rhopressa (Drug) $16.74
- EYSUVIS (Drug) $16.63
- BESIVANCE (Drug) $15.69
- STELLARIS (Device) $15.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.